SCHEMBL7528504

SCHEMBL7528504

COc1c(C=O)cccc1-c1ccsc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
ERN1 O75460 5/20 0.48
TUBB4A P04350 6/20 0.43
TUBB P07437 6/20 0.43
TUBA3C P0DPH7 6/20 0.43
TUBA1B P68363 6/20 0.43
TUBA4A P68366 6/20 0.43
TUBB4B P68371 6/20 0.43
TUBB3 Q13509 6/20 0.43
TUBB2A Q13885 6/20 0.43
TUBB8 Q3ZCM7 6/20 0.43
TUBA3E Q6PEY2 6/20 0.43
TUBA1A Q71U36 6/20 0.43
TUBA1C Q9BQE3 6/20 0.43
TUBB6 Q9BUF5 6/20 0.43
TUBB2B Q9BVA1 6/20 0.43
TUBB1 Q9H4B7 6/20 0.43
SRC P12931 1/20 0.39
TLR2 O60603 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1642697 0.79 CA1 (0.56) CA1CA2ERN1SRCTLR2
SCHEMBL609426 0.79 ERN1 (0.49) ERN1MAOB
SCHEMBL18002071 0.78 ERN1 (0.48) ERN1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL8503115 0.78 CA1 (0.51) CA1CA2ERN1SRCTLR2
SCHEMBL7525014 0.76 ERN1 (0.48) ERN1MAOB
SCHEMBL6764760 0.76 TUBB4A (0.44) CA1CA2TUBB4ATUBBTUBA3C
SCHEMBL7533951 0.76 ERN1 (0.51) ERN1TLR2TLR1TLR6
SCHEMBL5373060 0.76 CA1 (0.53) CA1CA2ERN1SRCTLR2
SCHEMBL184461 0.75 CA1 (0.51) CA1CA2ERN1TUBB4ATUBB
SCHEMBL5737981 0.75 CA1 (0.51) CA1CA2ERN1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187824-B1 NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PF MEDICAMENT (FR) 2002-11-13 EP disclosed
US-6417222-B1 DRUGS FOR PSYCHOLOGICAL DISORDERS OR COGNITION ACTIVATORS PIERRE FABRE MEDICAMENT (FR) 2002-07-09 US disclosed
EP-1187824-A2 NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2002-03-20 EP disclosed
WO-2000058282-A2 NOVEL [(2-SUBSTITUTED-5 -[3-THIENYL) -BENZYL]-[2- ([2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2000-10-05 WO disclosed